0001835615
Company
Meihua International Medical Technologies Co., Ltd.
Surgical & Medical Instruments & Apparatus · MHUAF
follow-on
effective
OTC
EFFECT
Filing Timeline
SEC EDGAR
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows DRS and marks the registration effective.
2026-02-26 · 9999999995-26-000681
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
Begins the tracked draft filing sequence after EFFECT.
2026-02-13 · 0001213900-26-016606
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows F-1/A and marks the registration effective.
2024-02-27 · 9999999995-24-000565
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
2024-02-23 · 0001213900-24-016302
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
2024-02-21 · 0001213900-24-015822
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows EFFECT in the pre-IPO sequence.
2024-02-06 · 0001213900-24-010298
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B4 and marks the registration effective.
2023-09-29 · 9999999995-23-002881
424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-02-17 · 0001213900-22-008227
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows F-1/A and registers the class of securities for exchange listing.
2022-02-15 · 0001213900-22-007800
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 8-A12B and marks the registration effective.
2022-02-15 · 9999999995-22-000465
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2022-02-08 · 0001213900-22-005873
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior FWP filing.
2022-02-03 · 0001213900-22-005093
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows F-1/A and supplements the active offering with updated prospectus details.
2022-02-03 · 0001213900-22-005104
FWP
supplemental
Free writing prospectus
Prospectus supplement or marketing filing that often updates active offering terms.
Follows F-1/A and supplements the active offering with updated prospectus details.
2022-01-25 · 0001213900-22-003554
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The company, a Cayman Islands exempted company with operations in China, faces risks related to Chinese government regulation, U.S. securities laws (including the HFCAA), and dividend distribution restrictions. The IPO aims to list shares on the Nasdaq Global Market under the symbol MHUA, with proceeds intended for research and development and expansion. The filing highlights structural cash flow mechanisms and regulatory challenges in China.
2021-12-29 · 0001213900-21-067820
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd., a Cayman Islands exempted company, is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The company operates in China through wholly-owned subsidiaries and faces risks related to Chinese government regulations, capital controls, and dividend restrictions. The IPO aims to list shares on the Nasdaq Global Market under the symbol MHUA, though there is no assurance of successful completion. The offering includes potential over-allotment options and underwriting discounts, with proceeds intended for research and development.
2021-12-02 · 0001213900-21-062899
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market under the symbol MHUA. The company, structured through Cayman Islands and Chinese subsidiaries, operates in the medical technology sector. The offering includes underwriter warrants and potential over-allotment options, with proceeds intended for research and development. The filing highlights risks related to Chinese regulatory scrutiny, capital controls, and tax implications.
2021-11-05 · 0001213900-21-056849
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market under the symbol MHUA. The company, a Cayman Islands exempted company with operations in China, has no prior public market for its shares. The offering includes underwriters' warrants and potential over-allotment options. The company is an emerging growth entity with risks tied to Chinese regulatory scrutiny, capital controls, and tax implications.
2021-10-21 · 0001213900-21-054048
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market under the symbol MHUA. The company, incorporated in the Cayman Islands, operates through wholly-owned subsidiaries in China. Prior to this offering, there was no public market for its shares. The IPO price is expected to be $[__________] per share, with proceeds intended for general corporate purposes. The company is an emerging growth company eligible for reduced reporting requirements.
2021-09-24 · 0001213900-21-049664
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market. The company, incorporated in the Cayman Islands, operates in China through wholly-owned subsidiaries. The offering includes underwriter warrants and an over-allotment option, with proceeds intended for general corporate purposes. The company is an emerging growth company under U.S. securities laws.
2021-09-13 · 0001213900-21-047519
F-1/A
amended
Amended foreign registration statement
Updated foreign registration statement filed after SEC comments or deal changes.
Updates the prior F-1 filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis, aiming to list on the Nasdaq Global Market. The company, structured as a Cayman Islands exempted company, operates primarily in China through wholly-owned subsidiaries. The offering includes underwriter warrants and an over-allotment option. The company is an emerging growth company eligible for reduced reporting requirements, with significant risks tied to Chinese regulatory environments and government oversight.
2021-08-31 · 0001213900-21-045895
F-1
filed
Initial foreign registration statement
Initial public filing for a foreign issuer submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The company, a Cayman Islands exempted company, operates in the medical technology sector in China. The offering is structured to raise up to $50 million, with underwriter warrants and an over-allotment option. The company is an emerging growth company, eligible for reduced reporting requirements, and plans to list on the Nasdaq Global Market. Prior to this offering, there was no public market for its shares.
2021-08-10 · 0001213900-21-041150
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares on a firm commitment basis. The offering involves underwriters' warrants and an over-allotment option. The company, a Cayman Islands exempted company, is an emerging growth company eligible for reduced reporting requirements. The filing includes details on the proposed offering price, underwriting discounts, and risks associated with the IPO.
2021-07-16 · 0001213900-21-037293
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Meihua International Medical Technologies Co., Ltd. filed a DRS/A amendment for its IPO, submitting a confidential draft registration statement under the Jumpstart Our Business Startups Act. The filing outlines the registration of ordinary shares and underwriter warrants, with an initial public offering price yet to be determined. The company, a Cayman Islands exempted company, plans to list on the Nasdaq Global Market. The offering is on a firm commitment basis, with underwriters selling shares and potential over-allotment options. The registration fee calculations and underwriting terms are detailed, including warrants exercisable at 120% of the offering price.
2021-06-07 · 0001213900-21-031088
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Meihua International Medical Technologies Co., Ltd. is conducting an initial public offering (IPO) of ordinary shares under Form F-1, with a proposed maximum offering price of $50 million. The company, incorporated in the Cayman Islands, operates in China and focuses on medical technologies. The IPO is underwritten by The Crone Law Group P.C., with plans to list on the Nasdaq Global Market. The filing highlights the company's status as an emerging growth company and notes the risks associated with investing in its shares, including regulatory and market uncertainties.
2020-12-31 · 0001213900-20-045708
Comparable Deals
2 comparable deals
Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 2 using nearest neighbors.
Recent News
No recent news stored for this issuer.